AMXI-5001:Dose Escalation Phase I + AMXI-5001:Dose Expansion Phase II for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Aug 2020: Trial registered, NCT04503265
  2. 12 Aug 2020: Trial started, NCT04503265

The trials

NCT04503265: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

State
Under way
Phase
Phase 1 and Phase 2
People
122 planned
Started
12 Aug 2020
Primary completion
Aug 2026
Arms
AMXI-5001 Treatment
Results
None posted
  1. 7 Aug 2020: Trial registered
  2. 12 Aug 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.